News

Press Releases

Viscira® Extends Strong Business Performance Through Q1 2017

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, continued its solid business performance into the first quarter of 2017. The company realized a 16% increase in booked revenue for Q1 2017 versus the same period in 2016. This financial result represents the company’s best start to a year ever and comes on top of a previous record booked revenue quarter in Q4 2016.

During the first quarter, Viscira added several major clients to expand its roster of leading pharmaceutical, biotech, and medical device customers. This group of companies is based both in the US and abroad, and includes the company’s first ever customer in China.

Since 2011, Viscira has worked with 21 of the world’s top 25 pharmaceutical companies and has served over 200 unique brands, achieving solid penetration across major products and therapeutic areas.

"It’s exciting to see that our clients continue to respond positively to our ongoing digital innovation and delivery performance. With this start, we have strong momentum for the remainder of 2017, and we look forward to our continued growth and evolution as a company," commented Dave Gulezian, President & CEO of Viscira.

To satisfy the growing demand, the company continues to aggressively recruit talented professionals across multiple functional areas and plans to increase its staff by around 10% this year. Interested candidates can access the company's updated career page to learn more about Viscira, review testimonials from current staff, and apply for a relevant position.

"We recognize how valuable our staff is to our ongoing success. It is very important that we continue to attract and hire the best and brightest people to make Viscira even stronger as a company," explained Amisha Hada, Associate Director of Human Resources.

Click here to read full article.

Viscira® Announces the Hire of New Scientific Director

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, today announced the addition of Russell Phillips, PhD, to its growing Medical Content team. Phillips joined the company last month in a core strategic leadership role as Scientific Director. Working closely with the executive team, he will help guide the development of medical communications and scientific content at Viscira, providing key strategic insights that will help the company’s medical writing and creative teams fully deliver on clients’ business objectives.

Phillips has had a long career in medical communications at innovative Bay Area healthcare companies, most recently at iRhythm Technologies, where he drove public relations, social media marketing, and sponsored research efforts. His communications experience spans multiple therapeutic areas, including neurology, diabetes, cardiology, and oncology. He also helped define the corporate communications strategy for the recent IPO of a digital healthcare solutions company.

"Russell is a fantastic addition to our team," said Heather McCune, Senior Scientific Director at Viscira. "His hire demonstrates the company’s continued commitment to delivering the highest level of content strategy and medical writing. We’re very excited to have Russell on board and look forward to the strategic insights he will bring to our internal teams and clients."

"I’m thrilled to join this successful Viscira team,” commented Phillips. “With their unique capabilities and innovative solutions, I’m excited to be with a company that is a recognized leader in life sciences digital marketing."

Phillips has a PhD in Experimental Psychology/Behavioral Neuroscience from NYU and completed postdoctoral work in Neurobiology at both Boston University and Stanford University.

Viscira's Medical Content team consists of expert PhD medical writers, marketing copywriters, and medical editors with extensive experience in a broad range of disease states and therapeutic areas, as well as an independent medical advisory board. Viscira’s content capabilities include content strategy, message development and refinement, creation of de novo content, digital optimization of existing content, and expert consulting regarding legal and regulatory compliance issues (including OPDP) across all phases of the product lifecycle.

Click here to read full article.

Viscira® Expands Company Headquarters in San Francisco

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, today announced that it has expanded its headquarters at 200 Vallejo Street to include an additional 5,000 square feet.

This nearly 40% increase in the company’s office space in San Francisco will better accommodate the company’s increasing staff and future growth plans. In 2016, Viscira's headcount grew by 10% to 15% in order to service additional clients and growing revenue. The company plans to add another 10% to 20% more staff in 2017 to further support anticipated growth.

Beyond the size difference, the new office space provides a more effective floor plan, a previously networked desk layout, and additional conference rooms, lounge areas, and work areas for creative collaboration, plus possibilities for future expansion.

"This is another positive development for Viscira that will allow us to better meet the needs of our employees and clients," stated Rick Barker, COO of Viscira."It's important that we continue to invest in our business operations and infrastructure to help maintain our high company standards for product quality and client service as we grow."

Overall, the company continues to expand its roster of leading pharmaceutical, biotech, and medical device customers, and it has achieved solid penetration across major brands and therapeutic areas. Since 2011, Viscira has worked with 19 of the world’s top 25 pharmaceutical companies and has served over 150 unique brands.

During 2016, Viscira won new business with several new major clients and continued to expand its volume of business with key existing clients. Viscira has also deepened its strategic capabilities in the past few years, achieving digital Agency of Record (dAOR) status for an increasing number of brands.

Click here to read full article.

Viscira® Welcomes New Senior Scientific Director

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, is proud to announce that Heather McCune, PhD, has rejoined the company as Senior Scientific Director. She will be responsible for guiding scientific strategy and medical content development for the company’s diverse base of domestic and global life sciences clients.

Heather brings over 10 years of medical content development experience back to Viscira. In addition to her previous role as Director of Medical Content at Viscira, Heather has held senior-level scientific positions at the medical communications agencies CMC and GeneEd, and in medical affairs at Cord Blood Registry. Heather has shaped content development efforts for some of the world’s largest pharma and biotech companies, providing support for nearly 400 digital, promotional, and medical education programs. McCune has also supported several launch brands, including those requiring OPDP preclearance review. She has experience in multiple therapeutic areas—namely, hematology/oncology (ALL, multiple myeloma, B-cell malignancies, hemophilia), solid tumor oncology (breast, lung, colorectal), neurology, cardiology, psychiatry, regenerative medicine, and rare disease.

Heather's academic credentials are as impressive as her pharma marketing and medical communications experience. She holds a BA in Biology from Macalester College and a PhD in Genetics from the University of Washington. She also has 10 years of bench research experience, gained during her doctoral studies, her postdoctoral fellowship in Biochemistry & Biophysics at UCSF, and research positions at the University of Minnesota and the University of Chicago. Heather commented, "I'm delighted to rejoin the Viscira team, and am very excited about the company’s dedication to providing best-in-class medical and promotional content development for our clients. Viscira has a proven commitment to this integral area, and I'm thrilled to lead and grow our talented medical content team."

Dave Gulezian, President and CEO of Viscira, said, "We are very happy to welcome Heather back to the Viscira family. Her depth of scientific knowledge is invaluable, as is her ability to work both strategically with our clients and collaboratively with members of our internal teams. It's energizing when we have talented former employees choose to return to the company."

Viscira's Medical Content team consists of expert PhD medical writers, marketing copywriters, and editors with extensive experience in a broad range of disease states and therapeutic areas, as well as an independent medical advisory board. Viscira’s content capabilities include content strategy, message development and refinement, creation of de novo content, digital optimization of existing content, and expert consulting regarding legal and regulatory compliance issues (including OPDP)—across all phases of the product lifecycle.

Viscira has immediate plans to hire additional members for its Medical Content team, including a Scientific Director, a Medical Editor, and Medical Writers. Please refer to the Careers Section of www.viscira.com for additional information.

Click here to read full article.

News by Year Press Releases - News page